Funded Tech Companies
Labrys Biologics
Headquartered in San Francisco, Labrys Biologics has funding from venBio, Canaan Partners and InterWest Partners.
Company Overview
Company Name
Labrys Biologics
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1700 Owens Street 595
San Francisco, CA 94158
USA
San Francisco, CA 94158
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Labrys Biologics is a private, venture-financed development stage biotechnology company focused on treatments for chronic migraine. Labrys' lead candidate, RN-307, is an anti-CGRP monoclonal antibody for the treatment of chronic migraine slated to enter Phase 2 clinical trials in 2013.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/4/2013
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven James
Chief Medical Officer
Marcelo Bigal
VP - Product Management
Michael Chang
VP - Regulatory Affairs
Michele Bronson
Company Investors
- venBio (Corey Goodman)
- Canaan Partners (Wende Hutton)
- InterWest Partners (Nina Kjellson)
- Sofinnova Ventures (Michael Powell)
Browse more funded tech companies:
Labrador Systems | Labrys Technologies
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs